glp 1 drugs type 1 diabetes GLP-1 Receptor Agonists as Treatments for 2 GLP-1-based therapies for diabetes, obesity
Description
One study found that 90% of individuals experienced adverse side effects in the first eight weeks of treatment, while another study found that 70% of diabetes patients discontinued use after 2 years due to feeling chronically sick
Discussion GLP-1RA fills increased rapidly between 2018 and 2023
J Appl Physiol
Keep in mind that they may cause side effects such as nausea, vomiting, or gastrointestinal discomfort
doi: 10.1038/s41591-022-02026-4
Real-world evidence has also emerged regarding dual GLP-1/GIP agonists
